Multicenter prospective cohort designs are however required to further assess the utility and clinical applicability of the expressions of DSPP, OPN and MMP-9, singly or in combination with DSPP in the overall estimation of tumor-free resection margins consistent with RFS in the surgical management of primary OSCC. The gene discussed is DSPP; the disease is neoplasm.